Glutaminase (GLS) (Middle Region) Peptide
Quick Overview for Glutaminase (GLS) (Middle Region) Peptide (ABIN977471)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-GLS antibody (Catalog #: ARP55098_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Glutaminase (GLS)
-
Background
-
Sahai (1983) [PubMed 6825316] demonstrated phosphate-activated glutaminase (EC 3.5.1.2) in human platelets. It is the major enzyme yielding glutamate from glutamine. Significance of the enzyme derives from its possible implication in behavior disturbances
Alias Symbols: AAD20, DKFZp686O15119, FLJ10358, GLS1, KIAA0838, GAC, GAM, KGA
Protein Interaction Partner: PARD6A,SNTA1,TAX1BP3,SNTA1
Protein Size: 669 -
Molecular Weight
- 73 kDa
-
Gene ID
- 2744
-
NCBI Accession
- NM_014905, NP_055720
-
UniProt
- O94925
Target
-